Swiss National Bank Biotechnology

Swiss National Bank

$146 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CAPR Capricor Therapeutics, Inc.	$280M	$933,000 0.0% of portfolio	67,400	Q4 2024 New
KROS Keros Therapeutics, Inc.	$278M	$933,000 0.0% of portfolio	59,000	Q4 2024 Added 4.8%
COGT Cogent Biosciences, Inc.	$426M	$923,000 0.0% of portfolio	118,400	Q4 2024 Reduced 2.47%
ERAS Erasca, Inc.	$186M	$906,000 0.0% of portfolio	361,200	Q4 2024 Added 9.55%
RLAY Relay Therapeutics, Inc.	$315M	$904,000 0.0% of portfolio	219,600	Q3 2024 Added 30.87%
ABUS Arbutus Biopharma Corp	$525M	$903,000 0.0% of portfolio	276,300	Q3 2024 New
HUMA Humacyte, Inc.	$202M	$869,000 0.0% of portfolio	172,100	Q4 2024 Added 5.78%
ARCT Arcturus Therapeutics Holdings Inc.	$308M	$809,000 0.0% of portfolio	47,700	Q2 2024 Added 1.06%
IMNM Immunome Inc.	$84.8M	$783,000 0.0% of portfolio	76,400	Q2 2024 Added 7.0%
KURA Kura Oncology, Inc.	$472M	$777,000 0.0% of portfolio	89,300	Q3 2024 Reduced 8.22%
CGEM Cullinan Oncology, Inc.	$366M	$763,000 0.0% of portfolio	62,700	Q4 2024 Reduced 14.81%
VERV Verve Therapeutics, Inc.	$313M	$750,000 0.0% of portfolio	133,100	Q4 2024 Added 15.64%
EYPT Eye Point Pharmaceuticals, Inc.	$199M	$745,000 0.0% of portfolio	100,000	Q4 2024 Added 3.52%
STOK Stoke Therapeutics, Inc.	$284M	$742,000 0.0% of portfolio	67,300	Q4 2024 Added 20.39%
IBRX Immunity Bio, Inc.	$1.26B	$701,000 0.0% of portfolio	274,000	Q4 2024 Added 1.48%
ANNX Annexon, Inc.	$109M	$692,000 0.0% of portfolio	135,000	Q4 2024 New
CVAC Cure Vac N.V.	$559M	$677,000 0.0% of portfolio	198,547	Q4 2023 Reduced 10.32%
TBPH Theravance Biopharma, Inc.	$616M	$675,000 0.0% of portfolio	71,742	Q2 2024 Reduced 2.71%
RGNX Regenxbio Inc.	$338M	$629,000 0.0% of portfolio	81,500	Q1 2024 Added 4.49%
ALLO Allogene Therapeutics, Inc.	$223M	$613,000 0.0% of portfolio	287,900	Q4 2024 Added 8.68%
URGN Uro Gen Pharma Ltd.	$255M	$602,000 0.0% of portfolio	56,600	Q3 2024 New
PHAT Phathom Pharmaceuticals, Inc.	$259M	$595,000 0.0% of portfolio	73,300	Q3 2024 Added 30.89%
ATXS Astria Therapeutics, Inc.	$86.5M	$586,000 0.0% of portfolio	66,600	Q4 2024 Added 13.07%
TRDA Entrada Therapeutics, Inc.	$284M	$567,000 0.0% of portfolio	32,800	Q2 2024 Added 42.61%
SVRA Savara Inc	$325M	$546,000 0.0% of portfolio	178,000	Q4 2024 Reduced 6.71%
ORIC Oric Pharmaceuticals, Inc.	$249M	$503,000 0.0% of portfolio	62,400	Q4 2024 Added 5.41%
PHVS Pharvaris N.V.	$534M	$503,000 0.0% of portfolio	26,257	Q3 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$500,000 0.0% of portfolio	194,650	Q1 2024 Added 18.22%
SAGE Sage Therapeutics, Inc.	$492M	$481,000 0.0% of portfolio	88,600	Q2 2024 Reduced 16.57%
YMAB Y M Abs Therapeutics, Inc.	$210M	$472,000 0.0% of portfolio	60,300	Q2 2024 New
SANA Sana Biotechnology, Inc.	$325M	$387,000 0.0% of portfolio	237,900	Q3 2024 Reduced 8.57%
OLMA Olema Pharmaceuticals, Inc.	$171M	$384,000 0.0% of portfolio	66,000	Q2 2024 Reduced 6.12%
LXRX Lexicon Pharmaceuticals, Inc.	$108M	$315,000 0.0% of portfolio	426,600	Q4 2024 Added 34.36%
TNGX Tango Therapeutics, Inc.	$129M	$293,000 0.0% of portfolio	94,900	Q4 2024 Added 13.11%
TYRA Tyra Biosciences, Inc.	$410M	$287,000 0.0% of portfolio	20,700	Q4 2024 Reduced 19.46%
FDMT 4 D Molecular Therapeutics, Inc.	$118M	$281,000 0.0% of portfolio	50,500	Q3 2024 Reduced 8.84%
ALEC Alector, Inc.	$107M	$249,000 0.0% of portfolio	131,900	Q1 2024 Added 6.46%
SAVA Cassava Sciences Inc	$66.2M	$210,000 0.0% of portfolio	89,000	Q3 2024 Added 10.29%
APLT Applied Therapeutics Inc.	$25M	$124,000 0.0% of portfolio	146,900	Q4 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	75,700	Q3 2024 Added 14.7%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.